KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 120 filers reported holding KRYSTAL BIOTECH INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,704 | +12.9% | 144 | +14.3% | 0.00% | – |
| Q2 2023 | $14,792 | +30.1% | 126 | -11.3% | 0.00% | – |
| Q1 2023 | $11,369 | -17.5% | 142 | -18.4% | 0.00% | – |
| Q4 2022 | $13,784 | +72.3% | 174 | +58.2% | 0.00% | – |
| Q3 2022 | $8,000 | +14.3% | 110 | +7.8% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 102 | +9.7% | 0.00% | – |
| Q1 2022 | $6,000 | -60.0% | 93 | -57.3% | 0.00% | – |
| Q4 2021 | $15,000 | +275.0% | 218 | +311.3% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 53 | +35.9% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |